Theratechnologies Inc. (TH.TO)
CAD 2.18
(0.46%)
CAD 2.18
(0.46%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 6.06 Million USD | -69.19% |
| 2022 | 19.68 Million USD | -32.44% |
| 2021 | 29.14 Million USD | 15.89% |
| 2020 | 25.14 Million USD | 20.14% |
| 2019 | 20.92 Million USD | 88.58% |
| 2018 | 11.09 Million USD | 52.93% |
| 2017 | 7.25 Million USD | -20.51% |
| 2016 | 9.12 Million USD | -3.93% |
| 2015 | 9.5 Million USD | 2.5% |
| 2014 | 9.26 Million USD | -10.49% |
| 2013 | 10.35 Million USD | -19.56% |
| 2012 | 12.87 Million USD | 28.67% |
| 2011 | 10 Million USD | 136.3% |
| 2010 | 4.23 Million USD | 78.29% |
| 2009 | 2.37 Million USD | 879.89% |
| 2008 | 242.37 Thousand USD | -88.51% |
| 2007 | 2.1 Million USD | 183.22% |
| 2006 | 744.63 Thousand USD | -54.91% |
| 2005 | 1.65 Million USD | 27.18% |
| 2004 | 1.29 Million USD | 70.27% |
| 2003 | 762.71 Thousand USD | -40.11% |
| 2002 | 1.27 Million USD | 74.35% |
| 2001 | 730.47 Thousand USD | 48.74% |
| 2000 | 491.11 Thousand USD | 623.2% |
| 1999 | 67.9 Thousand USD | -73.92% |
| 1998 | 260.41 Thousand USD | 270.57% |
| 1997 | 70.27 Thousand USD | -96.95% |
| 1996 | 2.3 Million USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 5.98 Million USD | 8.22% |
| 2024 Q1 | 6.3 Million USD | 3.91% |
| 2024 Q2 | 5.53 Million USD | -12.2% |
| 2023 Q1 | 15.11 Million USD | -23.25% |
| 2023 FY | 6.06 Million USD | -69.19% |
| 2023 Q4 | 6.06 Million USD | -9.77% |
| 2023 Q3 | 6.72 Million USD | -26.62% |
| 2023 Q2 | 9.16 Million USD | -39.36% |
| 2022 Q4 | 19.68 Million USD | -14.92% |
| 2022 FY | 19.68 Million USD | -32.44% |
| 2022 Q3 | 23.14 Million USD | -7.35% |
| 2022 Q2 | 24.97 Million USD | -4.43% |
| 2022 Q1 | 26.13 Million USD | -10.32% |
| 2021 Q3 | 27.29 Million USD | -4.5% |
| 2021 Q2 | 28.57 Million USD | 4.51% |
| 2021 FY | 29.14 Million USD | 15.89% |
| 2021 Q4 | 29.14 Million USD | 6.77% |
| 2021 Q1 | 27.34 Million USD | 8.75% |
| 2020 Q1 | 20.67 Million USD | -1.24% |
| 2020 Q4 | 25.14 Million USD | -2.04% |
| 2020 Q3 | 25.66 Million USD | 3.78% |
| 2020 Q2 | 24.73 Million USD | 19.67% |
| 2020 FY | 25.14 Million USD | 20.14% |
| 2019 Q1 | 11.5 Million USD | 3.64% |
| 2019 FY | 20.92 Million USD | 88.58% |
| 2019 Q2 | 12.86 Million USD | 11.82% |
| 2019 Q4 | 20.92 Million USD | 62.74% |
| 2019 Q3 | 12.86 Million USD | -0.01% |
| 2018 Q4 | 11.09 Million USD | 28.42% |
| 2018 FY | 11.09 Million USD | 52.93% |
| 2018 Q3 | 8.64 Million USD | 0.11% |
| 2018 Q2 | 8.63 Million USD | 16.83% |
| 2018 Q1 | 7.38 Million USD | 1.83% |
| 2017 FY | 7.25 Million USD | -20.51% |
| 2017 Q4 | 7.25 Million USD | -11.42% |
| 2017 Q3 | 8.19 Million USD | -7.41% |
| 2017 Q1 | 8.72 Million USD | -4.42% |
| 2017 Q2 | 8.84 Million USD | 1.41% |
| 2016 Q3 | 9.64 Million USD | -0.38% |
| 2016 FY | 9.12 Million USD | -3.93% |
| 2016 Q1 | 8.91 Million USD | -6.16% |
| 2016 Q2 | 9.67 Million USD | 8.56% |
| 2016 Q4 | 9.12 Million USD | -5.33% |
| 2015 FY | 9.5 Million USD | 2.5% |
| 2015 Q3 | 9.65 Million USD | -3.08% |
| 2015 Q4 | 9.5 Million USD | -1.57% |
| 2015 Q2 | 9.96 Million USD | 5.82% |
| 2015 Q1 | 9.41 Million CAD | 1.54% |
| 2014 FY | 9.26 Million USD | -10.49% |
| 2014 Q4 | 9.26 Million USD | -3.81% |
| 2014 Q2 | 9.33 Million USD | 3.88% |
| 2014 Q1 | 8.99 Million USD | -13.19% |
| 2014 Q3 | 9.63 Million USD | 3.19% |
| 2013 Q4 | 10.35 Million USD | -3.84% |
| 2013 FY | 10.35 Million USD | -19.56% |
| 2013 Q3 | 10.77 Million USD | -13.01% |
| 2013 Q2 | 12.38 Million USD | -4.98% |
| 2013 Q1 | 13.03 Million USD | 1.21% |
| 2012 Q3 | 14.01 Million USD | 1.67% |
| 2012 FY | 12.87 Million USD | 28.67% |
| 2012 Q2 | 13.78 Million USD | 1.01% |
| 2012 Q1 | 13.65 Million USD | 36.43% |
| 2012 Q4 | 12.87 Million USD | -8.17% |
| 2011 Q4 | 10 Million USD | -7.58% |
| 2011 FY | 10 Million USD | 136.3% |
| 2011 Q3 | 10.82 Million USD | 35.26% |
| 2011 Q2 | 8 Million USD | 69.66% |
| 2011 Q1 | 4.71 Million USD | 11.42% |
| 2010 Q4 | 4.23 Million USD | -2.07% |
| 2010 Q1 | 2.14 Million USD | -9.83% |
| 2010 FY | 4.23 Million USD | 78.29% |
| 2010 Q2 | 4.26 Million USD | 98.97% |
| 2010 Q3 | 4.32 Million USD | 1.47% |
| 2009 Q2 | 1.46 Million USD | 16.47% |
| 2009 Q3 | 1.45 Million USD | -0.48% |
| 2009 Q4 | 2.37 Million USD | 63.19% |
| 2009 FY | 2.37 Million USD | 879.89% |
| 2009 Q1 | 1.25 Million USD | 418.04% |
| 2008 Q1 | 1.18 Million USD | -43.88% |
| 2008 FY | 242.37 Thousand USD | -88.51% |
| 2008 Q4 | 242.37 Thousand USD | 0.97% |
| 2008 Q3 | 240.04 Thousand USD | -59.75% |
| 2008 Q2 | 596.39 Thousand USD | -49.61% |
| 2007 Q3 | 2.26 Million USD | -7.42% |
| 2007 Q4 | 2.1 Million USD | -6.87% |
| 2007 FY | 2.1 Million USD | 183.22% |
| 2007 Q1 | 1.85 Million USD | 149.55% |
| 2007 Q2 | 2.44 Million USD | 31.63% |
| 2006 Q2 | 2.17 Million USD | 21.69% |
| 2006 Q1 | 1.78 Million USD | 8.18% |
| 2006 FY | 744.63 Thousand USD | -54.91% |
| 2006 Q3 | 2.04 Million USD | -5.8% |
| 2006 Q4 | 744.63 Thousand USD | -63.64% |
| 2005 FY | 1.65 Million USD | 27.18% |
| 2005 Q2 | 2.08 Million USD | 66.42% |
| 2005 Q1 | 1.25 Million USD | -3.39% |
| 2005 Q3 | 2.23 Million USD | 6.82% |
| 2005 Q4 | 1.65 Million USD | -25.95% |
| 2004 Q4 | 1.29 Million USD | 22.91% |
| 2004 Q3 | 1.05 Million USD | 59.24% |
| 2004 Q2 | 663.53 Thousand USD | -2.6% |
| 2004 Q1 | 681.25 Thousand USD | -10.68% |
| 2004 FY | 1.29 Million USD | 70.27% |
| 2003 Q1 | 2.37 Million USD | 86.42% |
| 2003 FY | 762.71 Thousand USD | -40.11% |
| 2003 Q4 | 762.71 Thousand USD | -66.31% |
| 2003 Q3 | 2.26 Million USD | -5.55% |
| 2003 Q2 | 2.39 Million USD | 0.97% |
| 2002 Q1 | 966.5 Thousand CAD | 32.31% |
| 2002 Q4 | 1.27 Million USD | -13.63% |
| 2002 Q3 | 1.47 Million CAD | 27.6% |
| 2002 Q2 | 1.15 Million CAD | 19.57% |
| 2002 FY | 1.27 Million USD | 74.35% |
| 2001 Q3 | 875.67 Thousand CAD | 4.69% |
| 2001 Q1 | 568.79 Thousand CAD | 15.82% |
| 2001 FY | 730.47 Thousand USD | 48.74% |
| 2001 Q2 | 836.41 Thousand CAD | 47.05% |
| 2001 Q4 | 730.47 Thousand CAD | -16.58% |
| 2000 Q1 | 68.91 Thousand CAD | 1.48% |
| 2000 Q3 | 194.18 Thousand USD | -3.02% |
| 2000 FY | 491.11 Thousand USD | 623.2% |
| 2000 Q4 | 491.11 Thousand CAD | 152.92% |
| 2000 Q2 | 200.22 Thousand USD | 190.53% |
| 1999 Q1 | 198.87 Thousand USD | -23.63% |
| 1999 Q2 | 135.64 Thousand USD | -31.8% |
| 1999 FY | 67.9 Thousand USD | -73.92% |
| 1999 Q4 | 67.9 Thousand USD | 1.49% |
| 1999 Q3 | 66.9 Thousand USD | -50.67% |
| 1998 Q3 | 126.55 Thousand USD | 84.33% |
| 1998 Q2 | 68.65 Thousand USD | -2.29% |
| 1998 Q1 | 70.26 Thousand USD | -0.01% |
| 1998 Q4 | 260.41 Thousand USD | 105.78% |
| 1998 FY | 260.41 Thousand USD | 270.57% |
| 1997 Q1 | 219.2 Thousand USD | 0.0% |
| 1997 Q3 | 143.98 Thousand USD | -33.85% |
| 1997 Q4 | 70.27 Thousand USD | -51.19% |
| 1997 FY | 70.27 Thousand USD | -96.95% |
| 1997 Q2 | 217.67 Thousand USD | -0.7% |
| 1996 FY | 2.3 Million USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Aurora Cannabis Inc. | 186.37 Million CAD | 96.745% |
| Avicanna Inc. | 4.54 Million CAD | -33.488% |
| Avant Brands Inc. | 28.93 Million CAD | 79.037% |
| Cardiol Therapeutics Inc. | -279.87 Thousand CAD | 2267.419% |
| Crescita Therapeutics Inc. | 6.12 Million CAD | 0.963% |
| Knight Therapeutics Inc. | 91.83 Million CAD | 93.395% |
| MediPharm Labs Corp. | 9.89 Million CAD | 38.721% |
| OrganiGram Holdings Inc. | 80.95 Million CAD | 92.507% |
| Canopy Growth Corporation | 77.29 Million CAD | 92.152% |
| Willow Biosciences Inc. | 221 Thousand CAD | -2644.796% |
| Auxly Cannabis Group Inc. | 31.42 Million CAD | 80.699% |